Sponsor

Dualitybio Inc.

United States 3524 Silverside Road Suite 35b, 19810-4929, United States

About the sponsor

Dualitybio Inc. is involved in clinical research for metastatic breast cancer, with a focus on hormone receptor positive and HER2-low disease. Its studies address treatment needs in patients with advanced breast tumors where HER2 expression is low and targeted options remain limited.

Hormone receptor positive breast cancer
HER2-low metastatic breast cancer
Progression-free survival

The research portfolio in this area reflects interest in therapeutic strategies for advanced breast cancer and biomarker-defined patient groups.

About Specializations

Dualitybio Inc. runs clinical trials in conditions such as Hepatocellular carcinoma, Squamous cell carcinoma of head and neck, Cervix carcinoma, Ovarian cancer, among others.